Bortezomib-induced cardiogenic shock in a multiple myeloma patient with K light-chain cardiac amyloidosis

Ann Hematol. 2022 Sep;101(9):2087-2088. doi: 10.1007/s00277-022-04858-z. Epub 2022 May 11.
No abstract available

Publication types

  • Letter

MeSH terms

  • Amyloidosis* / chemically induced
  • Amyloidosis* / complications
  • Amyloidosis* / drug therapy
  • Bortezomib / adverse effects
  • Dexamethasone / adverse effects
  • Humans
  • Immunoglobulin Light-chain Amyloidosis* / complications
  • Immunoglobulin Light-chain Amyloidosis* / drug therapy
  • Multiple Myeloma* / complications
  • Multiple Myeloma* / drug therapy
  • Shock, Cardiogenic / chemically induced

Substances

  • Bortezomib
  • Dexamethasone